カテゴリー： Stratistics MRC, 世界, 医療/バイオ

外陰部＆膣萎縮症治療のグローバル市場（～2027）：尿検査、内診、酸バランス検査

◆英語タイトル：Vulvar and Vaginal Atrophy Therapy Market Forecasts to 2028 – Global Analysis By Diagnosis (Urine Test, Pelvic Examination, Acid Balance Test), Treatment (Selective Estrogen Receptor Modulators, Non Hormonal Therapy, Laser Therapy) and By Geography
	◆商品コード：SMR23MR032 ◆発行会社（リサーチ会社）：Stratistics MRC ◆発行日：2022年9月 ◆ページ数：約150 ◆レポート形式：英語 / Eメール ◆納品方法：英語 ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Global Site License	USD4,150 ⇒換算￥630,800	見積依頼/購入/質問フォーム
PDF	USD7,500 ⇒換算￥1,140,000	見積依頼/購入/質問フォーム

★Stratistics MRCに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）

❖ レポートの概要 ❖

Stratistics MRC社の本調査レポートでは、世界の外陰部＆膣萎縮症治療市場規模が予測期間中にCAGR 12%で成長すると展望しています。本書では、外陰部＆膣萎縮症治療の世界市場について徹底的に調査・分析を行い、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、診断別（尿検査、内診、酸バランス検査）分析、治療別（選択的エストロゲン受容体モジュレーター、非ホルモン療法、レーザー療法）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、最近の動向、企業情報などを考察しています。また、Viveve, Inc., VenusConcept, ThermiGen LLC, TherapeuticsMD, Inc., Lutronic, Hologic, Fotona, BTL Group of Companies, Almirall, Alma Lasers, Sinclairなどの企業情報を収録しています。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の外陰部＆膣萎縮症治療市場規模：診断別
- 尿検査の市場規模
- 内診の市場規模
- 酸バランス検査の市場規模
・世界の外陰部＆膣萎縮症治療市場規模：治療別
- 選択的エストロゲン受容体モジュレーターの市場規模
- 非ホルモン療法の市場規模
- レーザー療法の市場規模
・世界の外陰部＆膣萎縮症治療市場規模：地域別
- 北米の外陰部＆膣萎縮症治療市場規模
- ヨーロッパの外陰部＆膣萎縮症治療市場規模
- アジア太平洋の外陰部＆膣萎縮症治療市場規模
- 南米の外陰部＆膣萎縮症治療市場規模
- 中東・アフリカの外陰部＆膣萎縮症治療市場規模
・最近の動向
・企業情報

Stratistics MRCによると、世界の外陰部＆膣萎縮症治療市場は予測期間中、年平均成長率12%で推移しています。外陰部＆膣萎縮症（VVA）は、閉経後の女性に影響を与える一般的な症状ですが、必ずしも症状があるとは限りません。閉経期を通じてエストロゲンレベルが低下するにつれて、膣上皮が薄くなり、膣の血流が低下し、膣の潤滑が低下します。

国立衛生研究所によると、米国では毎年130万人の女性が閉経を迎えています。閉経を迎える年齢は、ほとんどが51～52歳です。しかし、世界の女性の約5％が40歳から45歳の間に早期閉経を経験し、1％が性染色体異常のために40歳以前に閉経し、永久卵巣不全になります。世界保健機関（WHO）によると、2020年には世界で230万人の女性が乳がんと診断されました。一方、米国国立がん研究所によると、2022年時点で、子宮体がんは米国における新規がん症例の3.4%を占めています。

市場の主要企業

外陰部＆膣萎縮症治療市場の主要企業には、Vulvar and Vaginal Atrophy Therapy Market include Viveve, Inc., VenusConcept, ThermiGen LLC, TherapeuticsMD, Inc., Lutronic, Hologic, Fotona, BTL Group of Companies, Almirall, Alma Lasers, Sinclairが含まれます。

主な動向

2021年2月：Viveve Medical Inc.は、同社の新規デュアルエネルギー技術装置について、韓国特許第10-2197234号「膣リモデリング装置および方法」を取得したと発表しました。

2022年6月：Sinclairは、非侵襲的で痛みのない膣若返り治療のためのV-VRハンドピースを発売しました。この装置は、膣の若返りのための同極RFによる臨床的に証明されたソリューションです。

対象となる診断
– 尿検査
– 骨盤内検査
– 酸バランス検査

対象となる治療
– 選択的エストロゲン受容体モジュレーター
– 非ホルモン療法
– レーザー療法
– ホルモン療法

適応症
– 膣乾燥症
– 膣のほてり
– 膣分泌物
– 性器のかゆみ
– 再発性尿路感染症
– 尿失禁
– 性交後の軽い出血
– 性交時の不快感
– 性行為中の膣潤滑の減少
– 膣管の短縮と引き締め
– 膣の灼熱感
– 性交疼痛症
– 尿路感染

対象となるエンドユーザー
– 外来手術センター
– 専門クリニック

対象地域
– 北米
米国
カナダ
メキシコ
– ヨーロッパ
ドイツ
英国
イタリア
フランス
スペイン
その他のヨーロッパ
– アジア太平洋
日本
中国
インド
オーストラリア
ニュージーランド
韓国
その他のアジア太平洋地域
– 南米
アルゼンチン
ブラジル
チリ
その他の南米諸国
– 中東・アフリカ
サウジアラビア
アラブ首長国連邦
カタール
南アフリカ
その他の中東・アフリカ

❖ レポートの目次 ❖

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Vulvar and Vaginal Atrophy Therapy Market, By Diagnosis
5.1 Introduction
5.2 Urine Test
5.3 Pelvic Examination
5.4 Acid Balance Test
6 Global Vulvar and Vaginal Atrophy Therapy Market, By Treatment
6.1 Introduction
6.2 Selective Estrogen Receptor Modulators
6.3 Non Hormonal Therapy
6.4 Laser Therapy
6.5 Hormonal Therapy
7 Global Vulvar and Vaginal Atrophy Therapy Market, By Indication
7.1 Introduction
7.2 Vaginal Dryness
7.3 Vaginal Burning
7.4 Vaginal Discharge
7.5 Genital Itching
7.6 Recurrent Urinary Tract Infections
7.7 Urinary Incontinence
7.8 Light Bleeding After Intercourse
7.9 Discomfort with Intercourse
7.10 Decreased Vaginal Lubrication During Sexual Activity
7.11 Shortening and Tightening of the Vaginal Canal
7.12 Burning Sensation in the Vagina
7.13 Dyspareunia
7.14 Urinary Tract Infection
8 Global Vulvar and Vaginal Atrophy Therapy Market, By End User
8.1 Hospitals
8.2 Ambulatory Surgical Centers
8.3 Specialty Clinics
9 Global Vulvar and Vaginal Atrophy Therapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Viveve, Inc.
11.2 VenusConcept
11.3 ThermiGen LLC
11.4 TherapeuticsMD, Inc.
11.5 Lutronic
11.6 Hologic
11.7 Fotona
11.8 BTL Group of Companies
11.9 Almirall
11.10 Alma Lasers
11.11 Sinclair
List of Tables
Table 1 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Region (2020-2028) (US $MN)
Table 2 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 3 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 4 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 5 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 6 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 7 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 8 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 9 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 10 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 11 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 12 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 13 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 14 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 15 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 16 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table17 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 18 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 19 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 20 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 21 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 22 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 23 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 24 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 25 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 26 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 27 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 28 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 29 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 30 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 31 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 32 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 33 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 34 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 35 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 36 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 37 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 38 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 39 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 40 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 41 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 42 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 43 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 44 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 45 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 46 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 47 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 48 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 49 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 50 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 51 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 52 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 53 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 54 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 55 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 56 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 57 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 58 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 59 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 60 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 61 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 62 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 63 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 64 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 65 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 66 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 67 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 68 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 69 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 70 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 71 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 72 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 73 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 74 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 75 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 76 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 77 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 78 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 79 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 80 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 81 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 82 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 83 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 84 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 85 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 86 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 87 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 88 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 89 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 90 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 91 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 92 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 93 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 94 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 95 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 96 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 97 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 98 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 99 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 100 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 101 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 102 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 103 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 104 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 105 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 106 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 107 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 108 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 109 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 110 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 111 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 112 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 113 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 114 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 115 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 116 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 117 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 118 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 119 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 120 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 121 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 122 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 123 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 124 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 125 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 126 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 127 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 128 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 129 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 130 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 131 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 132 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 133 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 134 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 135 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 136 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 137 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 138 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 139 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 140 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 141 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 142 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 143 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 144 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 145 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 146 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 147 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 148 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 149 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 150 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 151 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 152 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 153 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 154 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 155 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 156 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 157 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 158 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 159 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 160 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 161 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 162 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 163 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 164 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 165 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 166 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 167 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 168 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 外陰部＆膣萎縮症治療のグローバル市場（～2027）：尿検査、内診、酸バランス検査(Vulvar and Vaginal Atrophy Therapy Market Forecasts to 2028 – Global Analysis By Diagnosis (Urine Test, Pelvic Examination, Acid Balance Test), Treatment (Selective Estrogen Receptor Modulators, Non Hormonal Therapy, Laser Therapy) and By Geography)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

外陰部＆膣萎縮症治療のグローバル市場（～2027）：尿検査、内診、酸バランス検査

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp